Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Onconova appoints James Marino board

This article was originally published in Scrip

Executive Summary

Newtown, Pennsylvania-based Onconova Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, has named James J Marino to its board of directors. Mr Marino was a partner at the global law firm of Dechert for 28 years where he was managing partner of the Princeton office. During this period, he advised numerous leading life science companies in connection with financings, acquisitions and strategic alliances. He served as the outside counsel for Onconova from its inception through and including its initial public offering. Previously, he was on the board of Pharmacopeia Drug Discovery from 2000-2006 and has worked in advisory capacities and on the boards of multiple non-profit organizations, including Robert Wood Johnson University Hospital.

You may also be interested in...



Snapshot: April Highlights

A selection of articles you might have missed from April 2022, including exclusive interviews, an in depth look at the impact of COVID-19 on clinical trial trends, and the latest Rising Leaders series. 

Transforming Patient Engagement At Novartis

Rising Leader Yolanda Tibbe, Novartis’s head of new commercial partnerships in Germany, talks about transformation at the Swiss big pharma and how to put ‘patients as customers’ thinking into action. 

In Vivo's 2022 Rising Leaders At A Glance

Top 30 Leaders: see the list of entrepreneurs and innovators highlighted in the third edition of In Vivo's Rising Leaders series. 

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC029242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel